Clinical Trial Update: Efficacy and Safety of AngongNiuhuang Pill in Patients With Acute Ischemic Stroke (ANGONG TRIAL) [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating efficacy and safety of AngongNiuhuang Pill in acute ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Angongniuhuang Pill

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Acute Ischemic Stroke | Phase 3 | Status: COMPLETED